News 
Market Data 
Discover
Replies to post #237018 on Kraig Biocraft Laboratories Inc (KBLB)
Monster Silk?
Monster Silk? was the first recombinant spider silk fiber product we developed. Monster Silk incorporates the natural elasticity of spider silk to make a silk fiber which is more flexible that conventional silk fibers and textiles. We have produced sample products using Monster Silk? including knit fabrics, gloves, and shirts in collaboration with textile mills. We expect that Monster Silk? will have market applications across the traditional textile markets where its increased flexibility will provide increased durability and comfort.
Risks Associated with Our Business
As an OTCQB listed Company, we have limited resources with pressing capital requirements as we attempt to ramp up production. We are mindful of the challenges involved in achieving growth without compromising our ability to manage our operating risks and comply with rules and regulations. As we are commercializing a new technology, no one is in a position to know all of the risks, obstacles, and hurdles that the Company will face as it works to commercialize its new technology. We are aware of numerous risks associated with our business, including:
? Our ability to continue as a going concern;
? Our ability to generate significant revenues and to become profitable;
? Our ability to estimate future expenses;
? Our ability to maintain an effective system of internal controls;
? Our ability to protect our intellectual property rights and to secure additional rights domestically and internationally;
? Our ability to successfully manage our growth domestically and internationally;
10
? Our ability to attract and retain the services of key personnel;
? Our reliance on independent third-party collaborators to develop and deliver products to market;
? Our reliance on key management personnel and future need for highly skilled personnel;
? Our ability to successfully develop sales and marketing for our products;
? Market acceptance of pricing and performance for products we develop;
? Our ability to generate sustainable earnings and net operating profits;
? Our ability to adapt to regulatory and technology changes impacting our industry;
? The potential for product liability claims regarding our products and the use of genetically modified organisms (?GMO?s?) in our production system;
? Actions taken or omitted to be taken by third parties including our suppliers and competitors, as well as legislative, regulatory, judicial and other governmental authorities;
? Competition in our industry;
? The loss of or failure to obtain any license or permit necessary or desirable in the operation of our business;
? The availability of additional capital to support development;
? An active, liquid, and orderly market for our common stock or Purchase Warrants may not develop;
? The Purchase Warrants may not have any value;
? Our production system is based upon living transgenic organisms;
? Our business, operations and plans and timelines could be adversely affected by the effects of health epidemics, including the recent COVID-19 pandemic; and,
? Other Factors which are unanticipated by management
? Certain other risks and uncertainties set forth elsewhere in this prospectus under the section titled ?Risk Factors?
Common Stock outstanding prior to completion of this offering (1) 950,905,044
Common Stock outstanding after full conversion of the Debentures and exercise of the S1 Warrants (2)
1,257,026,207
03/24/22 6:44 AM
"We may be unable to generate significant revenues and may never become profitable.
We generated $0 and $0, in revenue for the years ended December 31, 2021 and 2020, respectively, and do not currently have any recurring sources of revenues, making it difficult to predict when we will be profitable. We expect to incur significant research and development costs for the foreseeable future. We may not be able to successfully market fiber products we produce in the future that will generate significant revenues. In addition, any revenues that we may generate may be insufficient for us to become profitable."
